The number of products awarded an orphan drug designation by the European Medicines Agency in 2017 fell by almost a third. In 2017, 144 designations were awarded compared with 209 in 2016, a fall of 31%.
The decline in designations by the EMA’s Committee for Orphan Medicinal Products (COMP) in 2017 bucks a trend that saw...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?